Pre-Clinical Safety (BioSafe) Committee Meeting

The BioSafe General Membership serves as a resource for BIO members and BIO staff by identifying and responding to key scientific and world-wide regulatory issues related to the preclinical safety evaluation of biopharmaceutical products on an as needed basis. General Members can participate in various expert working groups, task forces and work streams related to the preclinical safety of biologics. 

For more information and to join the Committee, please contact Surea Gainey (sgainey@bio.org).